Sepideh Mirzaei, Mohammad Hossein Gholami, Kiavash Hushmandi, Farid Hashemi, Amirhossein Zabolian, Israel Canadas, Ali Zarrabi, Noushin Nabavi, Amir Reza Aref, Francesco Crea, Yuzhuo Wang, Milad Ashrafizadeh, Alan Prem Kumar. The long and short non-coding RNAs modulating EZH2 signaling in cancer. J Hematol Oncol 2022;15
Cui Wei. The multifaceted roles of matrix metalloproteinases in lung cancer. Front. Oncol. 2023;13
Priya Chatterji, Julie Douchin, Véronique Giroux. Demystifying the Differences Between Tumor-Initiating Cells and Cancer Stem Cells in Colon Cancer. Curr Colorectal Cancer Rep 2018;14:242
Andrea Jemma, Alessandra Ardizzoia, Serena Redaelli, Angela Bentivegna, Marialuisa Lavitrano, Donatella Conconi. Prognostic Relevance of Copy Number Losses in Ovarian Cancer. Genes 2024;15:1487
Qi Tang, Dan Yin, Yao Wang, Wenxuan Du, Yuhan Qin, Anni Ding, Hanmei Li. Cancer Stem Cells and Combination Therapies to Eradicate Them. CPD 2020;26:1994
Claire A. Walsh, Nina Akrap, Elena Garre, Ylva Magnusson, Hannah Harrison, Daniel Andersson, Emma Jonasson, Svanheidur Rafnsdottir, Hani Choudhry, Francesca Buffa, Jiannis Ragoussis, Anders Ståhlberg, Adrian Harris, Göran Landberg, Nehad M. Alajez. The mevalonate precursor enzyme HMGCS1 is a novel marker and key mediator of cancer stem cell enrichment in luminal and basal models of breast cancer. PLoS ONE 2020;15:e0236187
Luigi Fattore, Rita Mancini, Gennaro Ciliberto. Cancer Stem Cells and the Slow Cycling Phenotype: How to Cut the Gordian Knot Driving Resistance to Therapy in Melanoma. Cancers 2020;12:3368
Na Liu, Shiqi Li, Nan Wu, Kin-Sang Cho. Acetylation and deacetylation in cancer stem-like cells. Oncotarget 2017;8:89315
Meriem Koual, Céline Tomkiewicz, German Cano-Sancho, Jean-Philippe Antignac, Anne-Sophie Bats, Xavier Coumoul. Environmental chemicals, breast cancer progression and drug resistance. Environ Health 2020;19
Seok Won Ham, Jung Yun Kim, Sunyoung Seo, Nayoung Hong, Min Ji Park, Yoonji Kim, Junseok Jang, Sehyeon Park, Silvee Jisoo Lee, Jun-Kyum Kim, Eun-Jung Kim, Sung-Ok Kim, Sung-Chan Kim, Jong-Whi Park, Hyunggee Kim. Annexin A2 Stabilizes Oncogenic JAG1 Intracellular Domain by Inhibiting Proteasomal Degradation in Glioblastoma Cells. IJMS 2023;24:14776
Yong Hoi Lee, Siew Wai Pang, Esther Revai Lechtich, Khalid Shah, Samson Eugin Simon, Suriyan Ponnusamy, Ramesh Narayanan, Chit Laa Poh, Kuan Onn Tan. Tricistronic expression of MOAP-1, Bax and RASSF1A in cancer cells enhances chemo-sensitization that requires BH3L domain of MOAP-1. J Cancer Res Clin Oncol 2020;146:1751
Hamed Rezayatmand, Mahboobeh Razmkhah, Iman Razeghian-Jahromi. Drug resistance in cancer therapy: the Pandora's Box of cancer stem cells. Stem Cell Res Ther 2022;13
Kate Dinneen, Anne-Marie Baird, Ciara Ryan, Orla Sheils. The Role of Cancer Stem Cells in Drug Resistance in Gastroesophageal Junction Adenocarcinoma. Front. Mol. Biosci. 2021;8
Eda Acikgoz, Burak Cem Soner, Berrin Ozdil, Mustafa Guven. CD133+/CD44+ prostate cancer stem cells exhibit embryo-like behavior patterns. Acta Histochemica 2021;123:151743
Daljeet Singh Dhanjal, Reena Singh, Varun Sharma, Eugenie Nepovimova, Vojtech Adam, Kamil Kuca, Chirag Chopra. Advances in Genetic Reprogramming: Prospects from Developmental
Biology to Regenerative Medicine. CMC 2024;31:1646
Kaishu Li, Haichao Li, Aonan He, Gengqiang Zhang, Yuyao Jin, Junbin Cai, Chenle Ye, Ling Qi, Yawei Liu. Deciphering the role of transcription factors in glioblastoma cancer stem cells. ABBS 2024;56:1245
Annabelle Trojan, Yu-Chun Lone, Ignacio Briceno, Jerzy Trojan. Anti-Gene IGF-I Vaccines in Cancer Gene Therapy: A Review of a
Case of Glioblastoma. CMC 2024;31:1983
Akhileshwar Kumar Srivastava, Dhruv Kumar, Divya Singh, Rajesh Kumar Singh. Xenobiotics in Chemical Carcinogenesis. 2024.
Juncheng Guo, Min Guo, Jinfang Zheng. Inhibition of Bone Morphogenetic Protein 2 Suppresses the Stemness Maintenance of Cancer Stem Cells in Hepatocellular Carcinoma via the MAPK/ERK Pathway. CMAR 2021;Volume 13:773
Lilei Peng, Jie Fu, Weijun Wang, Florence Hofman, Thomas Chen, Ligang Chen. Distribution of cancer stem cells in two human brain gliomas. Oncol Lett 2018
Liwen Zhang, Rong Ma, Mengcong Gao, Yanyun Zhao, Xuemei Lv, Wenjing Zhu, Li Han, Panpan Su, Yue Fan, Yuanyuan Yan, Lin Zhao, Heyao Ma, Minjie Wei, Miao He. SNORA72 Activates the Notch1/c-Myc Pathway to Promote Stemness Transformation of Ovarian Cancer Cells. Front. Cell Dev. Biol. 2020;8
Jingjin Ma, Zhiyu Chen, Qiaochu Li, Linbang Wang, Jiaxing Chen, Xinyu Yang, Chaohua Yang, Zhengxue Quan. RARRES2 is involved in the “lock-and-key” interactions between osteosarcoma stem cells and tumor-associated macrophages. Sci Rep 2024;14
Monica Marzagalli, Roberta Manuela Moretti, Elio Messi, Marina Montagnani Marelli, Fabrizio Fontana, Alessia Anastasia, Maria Rosa Bani, Giangiacomo Beretta, Patrizia Limonta. Targeting melanoma stem cells with the Vitamin E derivative δ-tocotrienol. Sci Rep 2018;8
Yu’e Liu, Chao Chen, Xinye Wang, Yihong Sun, Jin Zhang, Juxiang Chen, Yufeng Shi. An Epigenetic Role of Mitochondria in Cancer. Cells 2022;11:2518
H�ctor Contreras, Fernanda L�pez‑Moncada, Enrique Castell�n. Cancer stem cell and mesenchymal cell cooperative actions in metastasis progression and hormone resistance in prostate cancer: Potential role of androgen and gonadotropin‑releasing hormone receptors (Review). Int J Oncol 2020
Binjie Huang, Xin Yan, Yumin Li. Cancer Stem Cell for Tumor Therapy. Cancers 2021;13:4814
Phei Er Saw, Erwei Song. Tumor Ecosystem. 2021.
Maher Abla, Anthony Waked, Stéphane Trombotto, Mira Maalouf. Synthesis and Evaluation of Anticancer Activity of Hyaluronic Acid/Vanillin Conjugates. Macro Chemistry & Physics 2022;223
Yuxing Chen, Chaoyu Xiao, Qingxin Fan, Ye Zhang, Qiu Huang, Yunsheng Ou. Multi-Omics Pan-Cancer Analysis of Procollagen N-Propeptidase Gene Family of ADAMTS as Novel Biomarkers to Associate with Prognosis, Tumor Immune Microenvironment, Signaling Pathways, and Drug Sensitivities. Front. Biosci. (Landmark Ed) 2024;29
Suvasmita Rath, Diptesh Chakraborty, Jyotsnarani Pradhan, Mohammad Imran Khan, Jagneshwar Dandapat. Epigenomic interplay in tumor heterogeneity: Potential of epidrugs as adjunct therapy. Cytokine 2022;157:155967
Xiao-zheng Zou, Xiu-hua Zhou, Ying-qi Feng, Jun-feng Hao, Bing Liang, Meng-wei Jia. Novel inhibitor of OCT1 enhances the sensitivity of human esophageal squamous cell carcinoma cells to antitumor agents. European Journal of Pharmacology 2021;907:174222
Cheol Gyu Park, Sang-Hun Choi, Seon Yong Lee, Kiyoung Eun, Min Gi Park, Junseok Jang, Hyeon Ju Jeong, Seong Jin Kim, Sohee Jeong, Kanghun Lee, Hyunggee Kim. Cytoplasmic LMO2-LDB1 Complex Activates STAT3 Signaling through Interaction with gp130-JAK in Glioma Stem Cells. Cells 2022;11:2031
Aude Brunel, Sophie Hombourger, Elodie Barthout, Serge Battu, Donat Kögel, Patrick Antonietti, Elise Deluche, Sofiane Saada, Stéphanie Durand, Fabrice Lalloué, Marie-Odile Jauberteau, Gaëlle Begaud, Barbara Bessette, Mireille Verdier. Autophagy inhibition reinforces stemness together with exit from dormancy of polydisperse glioblastoma stem cells. Aging 2021;13:18106
Kamal Shaik Fakiruddin, Moon Lim, Norshariza Nordin, Rozita Rosli, Zubaidah Zakaria, Syahril Abdullah. Targeting of CD133+ Cancer Stem Cells by Mesenchymal Stem Cell Expressing TRAIL Reveals a Prospective Role of Apoptotic Gene Regulation in Non-Small Cell Lung Cancer. Cancers 2019;11:1261
Haizhan Feng, Yahui Dong, Kunling Chen, Zicong You, Junyan Weng, Peiqiao Liang, Fujun Shi. Sphingomyelin synthase 2 promotes the stemness of breast cancer cells via modulating NF-κB signaling pathway. J Cancer Res Clin Oncol 2024;150
Marta Turati, Alexandra Mousset, Nervana Issa, Andrei Turtoi, Roberto Ronca. TGF-β mediated drug resistance in solid cancer. Cytokine & Growth Factor Reviews 2023;71-72:54
Georgia Kyriakou, Maria Melachrinou. Cancer stem cells, epigenetics, tumor microenvironment and future therapeutics in cutaneous malignant melanoma: a review. Future Oncol. 2020;16:1549
Ethan J. Kilmister, Swee T. Tan. The Role of the Renin–Angiotensin System in the Cancer Stem Cell Niche. J Histochem Cytochem. 2021;69:835
Gang Zhao, Xiaozhen Wang, Limei Qu, Zhu Zhu, Jinghui Hong, Haiqin Hou, Zuonong Li, Jun Wang, Zheng Lv. The Clinical and Molecular Characteristics of Sex-Determining Region Y-Box 2 and its Prognostic Value in Breast Cancer: A Systematic Meta-Analysis. Breast Care 2021;16:16
Seok Won Ham, Jun-Kyum Kim, Hee-Young Jeon, Eun-Jung Kim, Xiong Jin, Kiyoung Eun, Cheol Gyu Park, Seon Yong Lee, Sunyoung Seo, Jung Yun Kim, Sang-Hun Choi, Nayoung Hong, Yong Yook Lee, Hyunggee Kim. Korean Red ginseng extract inhibits glioblastoma propagation by blocking the Wnt signaling pathway. Journal of Ethnopharmacology 2019;236:393
Anine Crous, Heidi Abrahamse. Aluminium (III) phthalocyanine chloride tetrasulphonate is an effective photosensitizer for the eradication of lung cancer stem cells. R. Soc. open sci. 2021;8:210148
Xueyang Zhang, Wenbo Du, Xizhi Huang, Haoting Zhong, Ning Hu. An overview of current research on cancer stem cells: a bibliometric analysis. Clin Transl Oncol 2024;26:2466
Liqun Yang, Pengfei Shi, Gaichao Zhao, Jie Xu, Wen Peng, Jiayi Zhang, Guanghui Zhang, Xiaowen Wang, Zhen Dong, Fei Chen, Hongjuan Cui. Targeting cancer stem cell pathways for cancer therapy. Sig Transduct Target Ther 2020;5
Yanguo Li, Chen Lin, Yidian Chu, Zhengyu Wei, Qi Ding, Shanshan Gu, Hongxia Deng, Qi Liao, Zhisen Shen, Xiangdong Fang. Characterization of Cancer Stem Cells in Laryngeal Squamous Cell Carcinoma by Single-cell RNA Sequencing. 2024;22
Kha-Liang Lee, Yung-Che Kuo, Yuan-Soon Ho, Yen-Hua Huang. Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness. Cancers 2019;11:1334
Elize Wolmarans, Sonja C. Boy, Sulette Nel, Anne E. Mercier, Michael Sean Pepper. Stem Cells: Biology and Engineering. 2019.
Jose G. Alvarez-Meythaler, Yoelsis Garcia-Mayea, Cristina Mir, Hiroshi Kondoh, Matilde E. LLeonart. Autophagy Takes Center Stage as a Possible Cancer Hallmark. Front. Oncol. 2020;10
Yan Dong, Zhuo Wan, Xiaotong Gao, Guodong Yang, Li Liu. Reprogramming Immune Cells for Enhanced Cancer Immunotherapy: Targets and Strategies. Front. Immunol. 2021;12
Beatrice Aramini, Valentina Masciale, Giulia Grisendi, Federica Bertolini, Michela Maur, Giorgia Guaitoli, Isca Chrystel, Uliano Morandi, Franco Stella, Massimo Dominici, Khawaja Husnain Haider. Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence. Cancers 2022;14:976
Jong-Wan Kwon, Jeong-Seop Oh, Sang Hyeok Seok, Hyeok-Won An, Yu Jin Lee, Na Yun Lee, Taehun Ha, Hyeon Ah Kim, Gyeong Min Yoon, Sung Eun Kim, Pu-Reum Oh, Su-Hyung Lee, Dominic C. Voon, Dae-Yong Kim, Jun Won Park. Combined inhibition of Bcl-2 family members and YAP induces synthetic lethality in metastatic gastric cancer with RASA1 and NF2 deficiency. Mol Cancer 2023;22
Mia C. Borlongan, Dipongkor Saha, Hongbin Wang. Tumor Microenvironment: A Niche for Cancer Stem Cell Immunotherapy. Stem Cell Rev and Rep 2024;20:3
E. P. Omelchuk, D. S. Kutilin, S. N. Dimitriadi, M. A. Gusarev, N. N. Timoshkina. Molecular genetic aspects of prostate cancer radioresistance. Bûll. sib. med. 2021;20:182
Zhaodong Ji, Wenjuan Tian, Wen Gao, Rongyu Zang, Huaying Wang, Gong Yang. Cancer-Associated Fibroblast-Derived Interleukin-8 Promotes Ovarian Cancer Cell Stemness and Malignancy Through the Notch3-Mediated Signaling. Front. Cell Dev. Biol. 2021;9
Souvick Roy, Shomereeta Roy, Madhabananda Kar, Abhik Chakraborty, Amit Kumar, Francesco Delogu, Shailendra Asthana, Manoor Prakash Hande, Birendranath Banerjee. Combined treatment with cisplatin and the tankyrase inhibitor XAV-939 increases cytotoxicity, abrogates cancer-stem-like cell phenotype and increases chemosensitivity of head-and-neck squamous-cell carcinoma cells. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2019;846:503084
Yan-jie Weng, Xiao-xiao Zhang, Xue Wu, Li-li Guo, Chang-yu Wang. Distinct Side Population Cell Subtypes Have Different Stemness Levels in Human Ovarian Cancer Cells. CURR MED SCI 2021;41:127
Michael O’Rawe, Ethan J. Kilmister, Theo Mantamadiotis, Andrew H. Kaye, Swee T. Tan, Agadha C. Wickremesekera. The Renin–Angiotensin System in the Tumor Microenvironment of Glioblastoma. Cancers 2021;13:4004
Bo Wu, Xiang Shi, Meixi Jiang, Hongxu Liu. Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment. Mol Cancer 2023;22
Shaohua Zhang, Xiaoman Ju, Qihong Yang, Yiying Zhu, Dongmei Fan, Guifeng Su, Lingmei Kong, Yan Li. USP47 maintains the stemness of colorectal cancer cells and is inhibited by parthenolide. Biochemical and Biophysical Research Communications 2021;562:21
Neda Barzgar Barough, Fakhrosadat Sajjadian, Nazila Jalilzadeh, Hajar Shafaei, Kobra Velaei. Understanding breast cancer heterogeneity through non-genetic heterogeneity. Breast Cancer 2021;28:777
Raefa Abou Khouzam, Hassan Venkatesh Goutham, Rania Faouzi Zaarour, Ali N Chamseddine, Amirtharaj Francis, Stéphanie Buart, Stéphane Terry, Salem Chouaib. Integrating tumor hypoxic stress in novel and more adaptable strategies for cancer immunotherapy. Seminars in Cancer Biology 2020;65:140
Yusheng Guo, Yanqiao Ren, Xiangjun Dong, Xuefeng Kan, Chuansheng Zheng. An Overview of Hepatocellular Carcinoma After Insufficient Radiofrequency Ablation. JHC 2022;Volume 9:343
Ambika Murugesan, B. Sekar, R. Saranyan, E. Manivannan, M. Rajmohan. A Review on Cancer Stem Cells in Vasculogenic Mimicry Formation: A New Dimension for Targeted Therapy. Journal of Advanced Oral Research 2021;12:34
Da‐Yong Zhang, Michael J. Monteiro, Jun‐Ping Liu, Wen‐Yi Gu. Mechanisms of cancer stem cell senescence: Current understanding and future perspectives. Clin Exp Pharma Physio 2021;48:1185
Farshad Farshidfar, Kahn Rhrissorrakrai, Chaya Levovitz, Cong Peng, James Knight, Antonella Bacchiocchi, Juan Su, Mingzhu Yin, Mario Sznol, Stephan Ariyan, James Clune, Kelly Olino, Laxmi Parida, Joerg Nikolaus, Meiling Zhang, Shuang Zhao, Yan Wang, Gang Huang, Miaojian Wan, Xianan Li, Jian Cao, Qin Yan, Xiang Chen, Aaron M. Newman, Ruth Halaban. Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis. Nat Commun 2022;13
Milan Teraiya, Helene Perreault, Vincent C. Chen. An overview of glioblastoma multiforme and temozolomide resistance: can LC-MS-based proteomics reveal the fundamental mechanism of temozolomide resistance?. Front. Oncol. 2023;13
Hua Ye, Kefeng Wu, Yi Liu, Yuzhen Zhu, Hui Luo, Wenying Zou. Zinc oxide nanoparticle attenuates chemotherapy resistance by inducing cell stemness progression of colorectal cancer via miR-1321/HIF-2α axis. Arabian Journal of Chemistry 2022;15:103938
Debbie O’Reilly, Paul Buchanan. Calcium channels and cancer stem cells. Cell Calcium 2019;81:21
Bin Yang, Yan Wang, Zhuoying Chen, Yi-Ming Feng, Liang-Liang Shi. Effects of Apatinib on the “Stemness” of Non-Small-Cell Lung Cancer Cells In Vivo and Its Related Mechanisms. Canadian Respiratory Journal 2020;2020:1
Vinayak Nayak, Sushmita Patra, Kshitij RB Singh, Bristy Ganguly, Das Nishant Kumar, Deepak Panda, Ganesh Kumar Maurya, Jay Singh, Sanatan Majhi, Rohit Sharma, Shyam S. Pandey, Ravindra Pratap Singh, Rout George Kerry. Advancement in precision diagnosis and therapeutic for triple-negative breast cancer: Harnessing diagnostic potential of CRISPR-cas & engineered CAR T-cells mediated therapeutics. Environmental Research 2023;235:116573
Cansu Tatar, Cigir Biray Avci, Eda Acikgoz, Gulperi Oktem. Doxorubicin-induced senescence promotes resistance to cell death by modulating genes associated with apoptotic and necrotic pathways in prostate cancer DU145 CD133+/CD44+ cells. Biochemical and Biophysical Research Communications 2023;680:194
Christopher M. Gromisch, Glaiza L. A. Tan, Khristine Amber Pasion, Ann-Marie Moran, Matthew S. Gromisch, Mark W. Grinstaff, Francis J. Carr, Victoria L. M. Herrera, Nelson Ruiz-Opazo. Humanized anti-DEspR IgG4S228P antibody increases overall survival in a pancreatic cancer stem cell-xenograft peritoneal carcinomatosis ratnu/nu model. BMC Cancer 2021;21
Marina Ibragimova, Matvey Tsyganov, Nikolai Litviakov. Tumour Stem Cells in Breast Cancer. IJMS 2022;23:5058
Shasha Ruan, Ming Lin, Yong Zhu, Lawrence Lum, Archana Thakur, Runming Jin, Wenlong Shao, Yalei Zhang, Yangyang Hu, Shiang Huang, Elaine M. Hurt, Alfred E. Chang, Max S. Wicha, Qiao Li. Integrin β4–Targeted Cancer Immunotherapies Inhibit Tumor Growth and Decrease Metastasis. 2020;80:771
Chaoyue Su, Jianye Zhang, Yosef Yarden, Liwu Fu. The key roles of cancer stem cell-derived extracellular vesicles. Sig Transduct Target Ther 2021;6
Mohd Anees, Priya Gupta, Harshdeep Kaur, Surender Kharbanda, Harpal Singh. Concomitant Delivery of Pirarubicin and Salinomycin Synergistically Enhanced the Efficacy of Cancer Therapy and Reduced the Risk of Cancer Relapse. AAPS PharmSciTech 2024;25
Juan Hou, Qing Chen, Yufeng Huang, Zhiwei Wu, De Ma. Caudatin blocks the proliferation, stemness and glycolysis of non-small cell lung cancer cells through the Raf/MEK/ERK pathway. Pharmaceutical Biology 2022;60:764
Sweta Ghosh, Subir Kumar Juin, Suchandra Bhattacharyya Majumdar, Subrata Majumdar. Crucial role of glucosylceramide synthase in the regulation of stem cell‐like cancer cells in B16F10 murine melanoma. Molecular Carcinogenesis 2021;60:840
Xiaoyuan Yu, Menglu Li, Chunyan Guo, Yuesheng Wu, Li Zhao, Qinying Shi, Jianbo Song, Bin Song. Therapeutic Targeting of Cancer: Epigenetic Homeostasis. Front. Oncol. 2021;11
Zeinab Mazloumi, Raheleh Farahzadi, Ali Rafat, Khadijeh Dizaji Asl, Mohammad Karimipour, Majid Montazer, Ali Akbar Movassaghpour, Alireza Dehnad, Hojjatollah Nozad Charoudeh. Effect of aberrant DNA methylation on cancer stem cell properties. Experimental and Molecular Pathology 2022;125:104757
R. Gajendra Reddy, Unis Ahmad Bhat, Sumana Chakravarty, Arvind Kumar. Advances in histone deacetylase inhibitors in targeting glioblastoma stem cells. Cancer Chemother Pharmacol 2020;86:165
Jing Yao, Xin‐Ping Wang, Jun Yang, Zhe Yang, Zheng‐Yun Zhang. SCF‐FBXL8 contributes to liver metastasis and stem‐cell‐like features in colorectal cancer cells by mediating ubiquitination and degradation of TP53. Clinical & Translational Med 2023;13
Sweta Ghosh, Subir Kumar Juin, Subrata Majumdar. Cancer stem cells and ceramide signaling: the cutting edges of immunotherapy. Mol Biol Rep 2020;47:8101
Lijuan Weng, Jianliang Zhou, Shenchao Guo, Nong Xu, Ruishuang Ma. The molecular subtyping and precision medicine in triple-negative breast cancer---based on Fudan TNBC classification. Cancer Cell Int 2024;24
Queenie Fernandes, Lubna Therachiyil, Abdul Q. Khan, Takwa Bedhiafi, Hesham M Korashy, Ajaz A. Bhat, Shahab Uddin. Shrinking the battlefield in cancer therapy: Nanotechnology against cancer stem cells. European Journal of Pharmaceutical Sciences 2023;191:106586
Justin D. Lathia, Huiping Liu. Overview of Cancer Stem Cells and Stemness for Community Oncologists. Targ Oncol 2017;12:387
Silvana Valdebenito, Daniela D'Amico, Eliseo Eugenin. Novel approaches for glioblastoma treatment: Focus on tumor heterogeneity, treatment resistance, and computational tools. Cancer Reports 2019;2
Mateus de Almeida Rainho, Andre Luiz Mencalha, Alessandra Alves Thole. Hypoxia effects on cancer stem cell phenotype in colorectal cancer: a mini-review. Mol Biol Rep 2021;48:7527
Luciana O. Almeida, Luan César Silva, Carolina Emerick, Juliana Amorim dos Santos, Rogerio M. Castilho, Cristiane H. Squarize. Head and neck cancer stem cell maintenance relies on mTOR signaling, specifically involving the mechanistic target of rapamycin complexes 1 and 2 (mTORC1 and mTORC2). Archives of Oral Biology 2024;157:105840
Mackenzie L. Coatham, Michael Jewer, Lynne-Marie Postovit. Biological Mechanisms and the Advancing Approaches to Overcoming Cancer Drug Resistance. 2024.
Pu Xia, Da-Hua Liu, Ze-Jun Xu, Fu Ren, Valeria Sorrenti. Cancer Stem Cell Markers for Urinary Carcinoma. Stem Cells International 2022;2022:1
Chu-lan Xiao, Zhi-peng Zhong, Can Lü, Bing-jie Guo, Jiao-jiao Chen, Tong Zhao, Zi-fei Yin, Bai Li. Physical exercise suppresses hepatocellular carcinoma progression by alleviating hypoxia and attenuating cancer stemness through the Akt/GSK-3β/β-catenin pathway. Journal of Integrative Medicine 2023;21:184
T. A. Pozniak, A. Y. Hancharou, V. M. Abashkin, A. I. Stanovaya, A. V. Prokhorov, D. G. Shcharbin. Circulating tumor cells and circulating cancer stem cells and their detection by the method of flow cytometry. Vescì Akademìì navuk Belarusì. Seryâ biâlagičnyh navuk 2021;66:370
J. Wei, Z. Liu, J. He, Q. Liu, Y. Lu, S. He, B. Yuan, J. Zhang, Y. Ding. Traditional Chinese medicine reverses cancer multidrug resistance and its mechanism. Clin Transl Oncol 2022;24:471
Lei Li, Chen Xun, Chun-Hong Yu. Role of microRNA-regulated cancer stem cells in recurrent hepatocellular carcinoma. World J Hepatol 2022;14:1985
Felipe C. O. B. Teixeira, Archana Vijaya Kumar, Sampath Kumar Katakam, Cinzia Cocola, Paride Pelucchi, Monika Graf, Ludwig Kiesel, Rolland Reinbold, Mauro S. G. Pavão, Burkhard Greve, Martin Götte. The Heparan Sulfate Sulfotransferases HS2ST1 and HS3ST2 Are Novel Regulators of Breast Cancer Stem-Cell Properties. Front. Cell Dev. Biol. 2020;8
Hongxia Huang, Jue Hou, Kewei Liu, Qin Liu, Liting Shen, Biying Liu, Qian Lu, Ni Zhang, Linrong Che, Jinyang Li, Shan Jiang, Bin Wang, Qinglian Wen, Lu Hu, Jian Gao. RAB27A‐dependent release of exosomes by liver cancer stem cells induces Nanog expression in their differentiated progenies and confers regorafenib resistance. J of Gastro and Hepatol 2021;36:3429
Yan Gu, Taosha Li, Anil Kapoor, Pierre Major, Damu Tang. Contactin 1: An Important and Emerging Oncogenic Protein Promoting Cancer Progression and Metastasis. Genes 2020;11:874
Eun-Young Koh, Keun-Sik Kim, Hee-Bin Park, Jong-Seok Kim, Pyung-Hwan Kim. Active Targeting of Versatile Nanocomplex Using the Novel Biomarker of Breast Cancer Stem Cells. IJMS 2022;24:685
Meiqi Li, Xianmei Zhong, Fukuan Du, Xu Wu, Mingxing Li, Yu Chen, Yueshui Zhao, Jing Shen, Zhongming Yang, Zhangang Xiao. Current Understanding and Future Perspectives on Hyperprogressive Disease Highlight the Tumor Microenvironment. The Journal of Clinical Pharma 2022;62:1059
Sha Zhou, Jianhong Peng, Liuniu Xiao, Caixia Zhou, Yujing Fang, Qingjian Ou, Jiayi Qin, Mengzhong Liu, Zhizhong Pan, Zhenlin Hou. TRIM25 regulates oxaliplatin resistance in colorectal cancer by promoting EZH2 stability. Cell Death Dis 2021;12
Yan Chen, Yu-Han Zhang, Jie Li, Lei Shi, Jia-Cheng Xie, Xue Han, Yu-Ting Chen, Meng Xiang, Bo-Wen Li, H. Rosie Xing, Jian-Yu Wang. Novel lncRNA Gm33149 modulates metastatic heterogeneity in melanoma by regulating the miR-5623-3p/Wnt axis via exosomal transfer. Cancer Gene Ther 2024;31:364
Basira Najafzadeh, Zahra Asadzadeh, Rohollah Motafakker Azad, Ahad Mokhtarzadeh, Amir Baghbanzadeh, Hajar Alemohammad, Mahdi Abdoli Shadbad, Parisa Vasefifar, Souzan Najafi, Behzad Baradaran. The oncogenic potential of NANOG: An important cancer induction mediator. Journal Cellular Physiology 2021;236:2443
Baoyu He, Jing Liang, Qianqian Qin, Yuqin Zhang, Shuo Shi, Jinghe Cao, Zhixin Zhang, Qingli Bie, Rou Zhao, Li Wei, Baogui Zhang, Bin Zhang. IL-13/IL-13RA2 signaling promotes colorectal cancer stem cell tumorigenesis by inducing ubiquitinated degradation of p53. Genes & Diseases 2024;11:495
Parisa Maleki Dana, Fatemeh Sadoughi, Zatollah Asemi, Bahman Yousefi. The role of polyphenols in overcoming cancer drug resistance: a comprehensive review. Cell Mol Biol Lett 2022;27
Xiaoli Mu, Yixin Zhou, Yongxin Yu, Mingyi Zhang, Jiyan Liu. The roles of cancer stem cells and therapeutic implications in melanoma. Front. Immunol. 2024;15
Weijing Liu, An Xie, Jing Xiong, Sheng Li, Lin Yang, Weipeng Liu. WDR3 promotes stem cell‐like properties in prostate cancer by inhibiting USF2‐mediated transcription of RASSF1A. The Journal of Gene Medicine 2023;25
Shalini Sakthivel, Manjita Srivastava, Muneesh Kumar Barman, Nerethika Ravichandiran, Salonee Martins, Meenakshi Singh, Kailash Chand, Subash C. Sonkar, Prudhvilal Bhukya. Handbook of Research on Advancements in Cancer Therapeutics. 2023.
Vitor Rodrigues da Costa, Rodrigo Pinheiro Araldi, Hugo Vigerelli, Fernanda D’Ámelio, Thais Biude Mendes, Vivian Gonzaga, Bruna Policíquio, Gabriel Avelar Colozza-Gama, Cristiane Wenceslau Valverde, Irina Kerkis. Exosomes in the Tumor Microenvironment: From Biology to Clinical Applications. Cells 2021;10:2617
Siyuan Qin, Jingwen Jiang, Yi Lu, Edouard C. Nice, Canhua Huang, Jian Zhang, Weifeng He. Emerging role of tumor cell plasticity in modifying therapeutic response. Sig Transduct Target Ther 2020;5
Yizhe Zhang, Isao Naguro, Amy E. Herr. In Situ Single‐Cell Western Blot on Adherent Cell Culture. Angewandte Chemie 2019;131:14067
Zi-Ning Lei, Qiu-Xu Teng, Jagadish Koya, Yangruiyu Liu, Zizhou Chen, Leli Zeng, Zhe-Sheng Chen, Shuo Fang, Jinxiang Wang, Yuchen Liu, Yihang Pan. The correlation between cancer stem cells and epithelial-mesenchymal transition: molecular mechanisms and significance in cancer theragnosis. Front. Immunol. 2024;15
Petra Gener, Joaquin Seras-Franzoso, Patricia González Callejo, Fernanda Andrade, Diana Rafael, Francesc Martínez, Sara Montero, Diego Arango, Joan Sayós, Ibane Abasolo, Simó Schwartz. Dynamism, Sensitivity, and Consequences of Mesenchymal and Stem-Like Phenotype of Cancer Cells. Stem Cells International 2018;2018:1
Sepideh Ardalan Khales, Mohammad Mahdi Forghanifard, Mohammad Reza Abbaszadegan, Seyed Ebrahim Hosseini. EZH2 deregulates BMP, Hedgehog, and Hippo cell signaling pathways in esophageal squamous cell carcinoma. Advances in Medical Sciences 2023;68:21
Jean Descarpentrie, Marcos J. Araúzo-Bravo, Zongsheng He, Alexia François, Álvaro González, Patricia Garcia-Gallastegi, Iker Badiola, Serge Evrard, Simon Pernot, John W. M. Creemers, Abdel-Majid Khatib. Role of Furin in Colon Cancer Stem Cells Malignant Phenotype and Expression of LGR5 and NANOG in KRAS and BRAF-Mutated Colon Tumors. Cancers 2022;14:1195
Mohd Farhan. Insights on the Role of Polyphenols in Combating Cancer Drug Resistance. Biomedicines 2023;11:1709
Huanjun Wang, Yan Mei, Cheng Luo, Qun Huang, Zifeng Wang, Guan-Ming Lu, Lili Qin, Zhun Sun, Chao-Wen Huang, Zhi-Wen Yang, Junxing Chen, Weiguo Yin, Chao-Nan Qian, Jianming Zeng, Lingwu Chen, Qibin Leng, Yan Guo, Guangshuai Jia. Single-Cell Analyses Reveal Mechanisms of Cancer Stem Cell Maintenance and Epithelial–Mesenchymal Transition in Recurrent Bladder Cancer. 2022;27:6265
Rihan Wu, Ru Ma, Xiaojun Duan, Jiandong Zhang, Kexin Li, Lei Yu, Mingyang Zhang, Pengxia Liu, Changshan Wang. Identification of specific prognostic markers for lung squamous cell carcinoma based on tumor progression, immune infiltration, and stem index. Front. Immunol. 2023;14
Diana Aparecida Dias Câmara, Paulo Luiz de Sá Junior, Ricardo Alexandre de Azevedo, Carlos Rogério Figueiredo, Rodrigo Pinheiro Araldi, Debora Levy, Dener Madeiro de Souza, Irina Kerkis. Identification of very small cancer stem cells expressing hallmarks of pluripotency in B16F10 melanoma cells and their reoccurrence in B16F10-derived clones. Experimental Cell Research 2020;391:111938
Simona Camero, Lucrezia Camicia, Francesco Marampon, Simona Ceccarelli, Rajeev Shukla, Olga Mannarino, Barry Pizer, Amalia Schiavetti, Antonio Pizzuti, Vincenzo Tombolini, Cinzia Marchese, Carlo Dominici, Francesca Megiorni. BET inhibition therapy counteracts cancer cell survival, clonogenic potential and radioresistance mechanisms in rhabdomyosarcoma cells. Cancer Letters 2020;479:71
Archana P. Thankamony, Kritika Saxena, Reshma Murali, Mohit Kumar Jolly, Radhika Nair. Cancer Stem Cell Plasticity – A Deadly Deal. Front. Mol. Biosci. 2020;7
Raed Obaid Saleh, Abdullah M. Shbeer, Raghu Jetti, Ibrahim Ahmed Robadi, Ahmed Hjazi, Anaheed Hussein Kareem, Maha Noori Shakir, Mohammed Qasim Alasheqi, Ahmed Alawadi, Ali Haslany. Association between lncRNAs with stem cells in cancer; a particular focus on lncRNA-CSCs axis in cancer immunopathogenesis. International Immunopharmacology 2024;136:112306
Gan Jiang, Huan Chen, Jialin Huang, Qingxiang Song, Yaoxing Chen, Xiao Gu, Zhenhuan Jiang, Yukun Huang, Yingying Lin, Junfeng Feng, Jiyao Jiang, Yinghui Bao, Gang Zheng, Jun Chen, Hongzhuan Chen, Xiaoling Gao. Tailored Lipoprotein‐Like miRNA Delivery Nanostructure Suppresses Glioma Stemness and Drug Resistance through Receptor‐Stimulated Macropinocytosis. Advanced Science 2020;7
Foram U. Vaidya, Abu Sufiyan Chhipa, Vinita Mishra, Vishal Kumar Gupta, Shiv Govind Rawat, Ajay Kumar, Chandramani Pathak. Molecular and cellular paradigms of multidrug resistance in cancer. Cancer Reports 2022;5
Fatemeh Tajik, Fahimeh Fattahi, Fereshteh Rezagholizadeh, Behnaz Bouzari, Pegah Babaheidarian, Masoud Baghai Wadji, Zahra Madjd. Nuclear overexpression of DNA damage-inducible transcript 4 (DDIT4) is associated with aggressive tumor behavior in patients with pancreatic tumors. Sci Rep 2023;13
Julie Tram, Laetitia Marty, Célima Mourouvin, Magali Abrantes, Ilham Jaafari, Raymond Césaire, Philippe Hélias, Benoit Barbeau, Jean-Michel Mesnard, Véronique Baccini, Laurent Chaloin, Jean-Marie Jr. Peloponese. The Oncoprotein Fra-2 Drives the Activation of Human Endogenous Retrovirus Env Expression in Adult T-Cell Leukemia/Lymphoma (ATLL) Patients. Cells 2024;13:1517
Paulo Assumpção, André Khayat, Taíssa Araújo, Williams Barra, Geraldo Ishak, Aline Cruz, Sidney Santos, Ândrea Santos, Samia Demachki, Paula Assumpção, Danielle Calcagno, Ney Santos, Mônica Assumpção, Fabiano Moreira, André Santos, Carolina Assumpção, Gregory Riggins, Rommel Burbano. The Small Bowel Cancer Incidence Enigma. Pathol. Oncol. Res. 2020;26:635
Cong He, Doulathunnisa Jaffar Ali, Smilin Bell Aseervatham G, Bo Sun, Zhongdang Xiao. Microvesicles – promising tiny players’ of cancer stem cells targeted liver cancer treatments: The interesting interactions and therapeutic aspects. Pharmacological Research 2021;169:105609
Junjie Zhao, Lixia Xu, Zihui Dong, Yize Zhang, Junhua Cao, Jie Yao, Jiyuan Xing. The LncRNA DUXAP10 Could Function as a Promising Oncogene in Human Cancer. Front. Cell Dev. Biol. 2022;10
Mengjiao Zhang, Jiqiang Zhang, Xuemei Liang, Ming Zhang. Stemness related lncRNAs signature for the prognosis and tumor immune microenvironment of ccRCC patients. BMC Med Genomics 2024;17
Laia Hernandez-Oller, Joaquin Seras-Franzoso, Fernanda Andrade, Diana Rafael, Ibane Abasolo, Petra Gener, Simo Schwartz Jr.. Extracellular Vesicles as Drug Delivery Systems in Cancer. Pharmaceutics 2020;12:1146
Michael E. Bregenzer, Eric N. Horst, Pooja Mehta, Caymen M. Novak, Taylor Repetto, Geeta Mehta. The Role of Cancer Stem Cells and Mechanical Forces in Ovarian Cancer Metastasis. Cancers 2019;11:1008
Oluwaseun Adebayo Bamodu, Chen-Chih Chung, Thomas R. Pisanic, Alexander T. H. Wu. The intricate interplay between cancer stem cells and cell-of-origin of cancer: implications for therapeutic strategies. Front. Oncol. 2024;14
Carmen-Bianca Crivii, Adina Bianca Boșca, Carmen Stanca Melincovici, Anne-Marie Constantin, Mariana Mărginean, Eleonora Dronca, Rada Suflețel, Diana Gonciar, Maria Bungărdean, Alina Șovrea. Glioblastoma Microenvironment and Cellular Interactions. Cancers 2022;14:1092
Muhammad Saif, E. I. Ager, Penelope Field, K. J. Lilischkis. The role of cancer stem cells and the therapeutic potential of TRX-E-002-1 in ovarian cancer. Expert Opinion on Orphan Drugs 2018;6:465
Qi Zhang, Wei Li. Correlation between amino acid metabolism and self-renewal of cancer stem cells: Perspectives in cancer therapy. WJSC 2022;14:267
Shihao Su, Yutong Chen, Pengfei Zhang, Ruijuan Ma, Wei Zhang, Jianing Liu, Tao Li, Hanjing Niu, Yi Cao, Bin Hu, Jinhua Gao, Hua Sun, Dong Fang, Jiajia Wang, Peng George Wang, Songqiang Xie, Chaojie Wang, Jing Ma. The role of Platinum(IV)-based antitumor drugs and the anticancer immune response in medicinal inorganic chemistry. A systematic review from 2017 to 2022. European Journal of Medicinal Chemistry 2022;243:114680
Liusheng Wu, Xiaofan Chen, Qi Zeng, Zelin Lai, Zhengyang Fan, Xin Ruan, Xiaoqiang Li, Jun Yan. NR5A2 gene affects the overall survival of LUAD patients by regulating the activity of CSCs through SNP pathway by OCLR algorithm and immune score. Heliyon 2024;10:e28282
Amira Osman, Miharu Oze, Said M. Afify, Ghmkin Hassan, Samah EL-Ghlban, Hend M. Nawara, Xiaoying Fu, Maram Hussein Zahra, Akimasa Seno, Ira Winer, David S. Salomon, Masaharu Seno. Tumor-associated macrophages derived from cancer stem cells. Acta Histochemica 2020;122:151628
Chenyue Zhang, Hui Wang, Xia Wang, Chenglong Zhao, Haiyong Wang. CD44, a marker of cancer stem cells, is positively correlated with PD-L1 expression and immune cells infiltration in lung adenocarcinoma. Cancer Cell Int 2020;20
Lei Du, Qi Cheng, Hao Zheng, Jinming Liu, Lei Liu, Quan Chen. Targeting stemness of cancer stem cells to fight colorectal cancers. Seminars in Cancer Biology 2022;82:150
Aimin Jiang, Juelan Ye, Ye Zhou, Baohua Zhu, Juan Lu, Silun Ge, Le Qu, Jianru Xiao, Linhui Wang, Chen Cai. Copper Death Inducer, FDX1, as a Prognostic Biomarker Reshaping Tumor Immunity in Clear Cell Renal Cell Carcinoma. Cells 2023;12:349
Su In Lee, Md Saiful Islam Roney, Jong Hyeok Park, Ji‐Young Baek, Jooyeon Park, Sang Kyum Kim, Song‐Kyu Park. Dopamine receptor antagonists induce differentiation of PC‐3 human prostate cancer cell‐derived cancer stem cell‐like cells. The Prostate 2019;79:720
Kalaivani Kalamohan, Paramasamy Gunasekaran, Syed Ibrahim. Gene coexpression network analysis of multiple cancers discovers the varying stem cell features between gastric and breast cancer. Meta Gene 2019;21:100576
Alessandra Loda, Francesco Semeraro, Silvia Parolini, Roberto Ronca, Sara Rezzola. Cancer stem-like cells in uveal melanoma: novel insights and therapeutic implications. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2024;1879:189104
Suzan Shenouda, Ketan Kulkarni, Yasser Abuetabh, Consolato Sergi . Cancer Stem Cells and their Management in Cancer Therapy. PRA 2020;15:212
Zhuoling Zou, Tinglan Luo, Xinyuan Wang, Bin Wang, Qing Li. Exploring the interplay between triple‐negative breast cancer stem cells and tumor microenvironment for effective therapeutic strategies. Journal Cellular Physiology 2024;239
Tomasz Wróbel, Marcin Luty, Jessica Catapano, Elżbieta Karnas, Małgorzata Szczygieł, Katarzyna Piwowarczyk, Damian Ryszawy, Grażyna Drabik, Ewa Zuba-Surma, Maciej Siedlar, Zbigniew Madeja, Martyna Elas, Jarosław Czyż. CD44+ cells determine fenofibrate-induced microevolution of drug-resistance in prostate cancer cell populations. 2020;38:1544
Si-Yu Wang, Qin-Chao Hu, Tong Wu, Juan Xia, Xiao-An Tao, Bin Cheng. Abnormal lipid synthesis as a therapeutic target for cancer stem cells. WJSC 2022;14:146
Riccardo Di Fiore, Sherif Suleiman, Rosa Drago-Ferrante, Yashwanth Subbannayya, Francesca Pentimalli, Antonio Giordano, Jean Calleja-Agius. Cancer Stem Cells and Their Possible Implications in Cervical Cancer: A Short Review. IJMS 2022;23:5167
Xiaoling Wen, Yingying Wu, Yanhui Lou, Yufang Xia, Xiao Yu. The roles of Linc-ROR in the regulation of cancer stem cells. Translational Oncology 2023;28:101602
Xiong Shu, Hui Wen Zhang, Shi Ya Liu, Li Xin Sun, Tao Zhang, Yu Liang Ran. Anti-ENO1 antibody combined with metformin against tumor resistance: a novel antibody-based platform. 2024;12:e16817
Yue Yang, Yuanyuan Lu, Chunhua Zhang, Qianqian Guo, Wenzhou Zhang, Ting Wang, Zhuolu Xia, Jing Liu, Xiangyu Cheng, Tao Xi, Feng Jiang, Lufeng Zheng. Phenazine derivatives attenuate the stemness of breast cancer cells through triggering ferroptosis. Cell. Mol. Life Sci. 2022;79
Yang Fan, Zijie Gao, Jianye Xu, Huizhi Wang, Qindong Guo, Hao Xue, Rongrong Zhao, Xing Guo, Gang Li. Identification and validation of SNHG gene signature to predict malignant behaviors and therapeutic responses in glioblastoma. Front. Immunol. 2022;13
Laetitia Seguin, Manon Durandy, Chloe C. Feral. Lung Adenocarcinoma Tumor Origin: A Guide for Personalized Medicine. Cancers 2022;14:1759
Liang Li, XueFeng Sun, Mei Zhang, BangShuo Zhang, Yi Yang, Sheng Wang. FOXN2, identified as a novel biomarker in serum, modulates the transforming growth factor-beta signaling pathway through its interaction with partitioning defective 6 homolog alpha, contributing to the pathogenesis of gastric cancer. Growth Factors 2024;42:62
Cong-Cong Wu, Yao Xiao, Hao Li, Liang Mao, Wei-Wei Deng, Guang-Tao Yu, Wen-Feng Zhang, Zhi-Jun Sun. Overexpression of FAM3C is associated with poor prognosis in oral squamous cell carcinoma. Pathology - Research and Practice 2019;215:772
Susmita Barman, Iram Fatima, Amar B. Singh, Punita Dhawan. Pancreatic Cancer and Therapy: Role and Regulation of Cancer Stem Cells. IJMS 2021;22:4765
Shalini Sakthivel, Manjita Srivastava, Muneesh Kumar Barman, Nerethika Ravichandiran, Salonee Martins, Meenakshi Singh, Kailash Chand, Subash C. Sonkar, Prudhvilal Bhukya. Research Anthology on Bioinformatics, Genomics, and Computational Biology. 2021.
Ashok Kumar Dhinakaran, Swarna Ganesh, Krishnan Venkatakrishnan, Bo Tan. Reprogramming the navigation of quantum probes in cancer initiating cells - Unlocking the pathway for next generation nanomedicine. Applied Materials Today 2022;28:101534
Eric N. Horst, Michael E. Bregenzer, Pooja Mehta, Catherine S. Snyder, Taylor Repetto, Yang Yang-Hartwich, Geeta Mehta. Personalized models of heterogeneous 3D epithelial tumor microenvironments: Ovarian cancer as a model. Acta Biomaterialia 2021;132:401
Fernanda López-Moncada, Enrique A. Castellón, Héctor R. Contreras. Cancer Stem Cell Markers and Related Network Pathways. 2021.
Tayebeh Oghabi Bakhshaiesh, Rezvan Esmaeili. Effects of noncoding RNAs in radiotherapy response in breast cancer: a systematic review. Cell Cycle 2022;21:883
Qihong Yang, Tong Qin, Tao An, Hongna Wu, Gang Xu, Jin Xiang, Kangfan Lei, Shaohua Zhang, Jie Xia, Guifeng Su, Dan Wang, Minggao Xue, Lingmei Kong, Wenxuan Zhang, Song Wu, Yan Li. Novel PORCN inhibitor WHN-88 targets Wnt/β-catenin pathway and prevents the growth of Wnt-driven cancers. European Journal of Pharmacology 2023;945:175628
Perla Pucci, Wallace Yuen, Erik Venalainen, David Roig Carles, Yuzhuo Wang, Francesco Crea. The Chemical Biology of Long Noncoding RNAs. 2023.
Saeedeh Keyvani-Ghamsari, Khatereh Khorsandi, Azhar Rasul, Muhammad Khatir Zaman. Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance. Clin Epigenet 2021;13
Yingxue Liu, Xiaoyan Zhang, Wenchao Gu, Hui Su, Xin Wang, Xu Wang, Jiayu Zhang, Midie Xu, Weiqi Sheng. Unlocking the crucial role of cancer-associated fibroblasts in tumor metastasis: Mechanisms and therapeutic prospects. Journal of Advanced Research 2024
Shihori Tanabe. Cancer Stem Cell Markers and Related Network Pathways. 2024.
Angel A. Gómez-Gallegos, Lizbeth Ramírez-Vidal, Jared Becerril-Rico, Elizabeth Pérez-Islas, Zuly J. Hernandez-Peralta, Mariel E. Toledo-Guzmán, Alejandro García-Carrancá, Elizabeth Langley, Angélica Hernández-Guerrero, Fernando López-Casillas, Roberto Herrera-Goepfert, Luis F. Oñate-Ocaña, Elizabeth Ortiz-Sánchez. CD24+CD44+CD54+EpCAM+ gastric cancer stem cells predict tumor progression and metastasis: clinical and experimental evidence. Stem Cell Res Ther 2023;14
Jian Zang, Min-Hua Zheng, Xiu-Li Cao, Yi-Zhe Zhang, Yu-Fei Zhang, Xiang-Yu Gao, Yuan Cao, Mei Shi, Hua Han, Liang Liang. Adenovirus infection promotes the formation of glioma stem cells from glioblastoma cells through the TLR9/NEAT1/STAT3 pathway. Cell Commun Signal 2020;18
Hiromi Kurokawa, Hiromu Ito, Masahiko Terasaki, Hirofumi Matsui. Hyperthermia enhances photodynamic therapy by regulation of HCP1 and ABCG2 expressions via high level ROS generation. Sci Rep 2019;9
Umadevi Bommu, Kranthi Kumar Konidala, Neeraja Pabbaraju, Suneetha Yeguvapalli. Gene microarray expression profile analysis of differentially expressed genes of potential alternative pathways in non–small cell lung cancer: In search of biomarkers. Gene Reports 2020;19:100633
Francesca Citron, Linda Fabris. Targeting Epigenetic Dependencies in Solid Tumors: Evolutionary Landscape Beyond Germ Layers Origin. Cancers 2020;12:682
Hee-Young Jeon, Cheol Gyu Park, Seok Won Ham, Sang-Hun Choi, Seon Yong Lee, Jung Yun Kim, Sunyoung Seo, Xiong Jin, Jun-Kyum Kim, Kiyoung Eun, Eun-Jung Kim, Hyunggee Kim. BRM270, a Compound from Natural Plant Extracts, Inhibits Glioblastoma Stem Cell Properties and Glioblastoma Recurrence. Journal of Medicinal Food 2017;20:838
Julhash U. Kazi. Mechanisms of Anticancer Therapy Resistance: The Role of Cancer Stem Cells. IJMS 2020;21:9006
Ishita Tandon, Asawari Waghmode, Nilesh Kumar Sharma. Cancer Stem Cells Equipped with Powerful Hedgehog Signaling and Better Epigenetic Memory: Avenues to Look for Cancer Therapeutics. CCDT 2019;19:877
Feng Cao, Jingtao Hu, Hongtao Yuan, Pengwei Cao, Yunsheng Cheng, Yong Wang. Identification of pyroptosis-related subtypes, development of a prognostic model, and characterization of tumour microenvironment infiltration in gastric cancer. Front. Genet. 2022;13
Vigneshwari Easwar Kumar, Roshni Nambiar, Cristabelle De Souza, Audrey Nguyen, Jeremy Chien, Kit S. Lam. Targeting Epigenetic Modifiers of Tumor Plasticity and Cancer Stem Cell Behavior. Cells 2022;11:1403
Yuanchun Fan, Huimin Cheng, Yueping Liu, Shihao Liu, Scott Lowe, Yaru Li, Rachel Bentley, Bethany King, John Pocholo W. Tuason, Qin Zhou, Chenyu Sun, Hui Zhang. Metformin anticancer: Reverses tumor hypoxia induced by bevacizumab and reduces the expression of cancer stem cell markers CD44/CD117 in human ovarian cancer SKOV3 cells. Front. Pharmacol. 2022;13
Ling-Ling Yu, Yuan Wang, Zu-Ke Xiao, Sheng-Song Chen. Heat shock protein B8 promotes proliferation and migration in lung adenocarcinoma A549 cells by maintaining mitochondrial function. Mol Cell Biochem 2021;476:187
Ralf Hass, Juliane von der Ohe, Hendrik Ungefroren. The Intimate Relationship among EMT, MET and TME: A T(ransdifferentiation) E(nhancing) M(ix) to Be Exploited for Therapeutic Purposes. Cancers 2020;12:3674
Zhenzhen Zhang, Weixing Yu, Min Zheng, Xinhua Liao, Jichuang Wang, Dayun Yang, Wenxian Lu, Long Wang, Sheng Zhang, Hekun Liu, Xiao Zhen Zhou, Kun Ping Lu. Pin1 inhibition potently suppresses gastric cancer growth and blocks PI3K/AKT and Wnt/β‐catenin oncogenic pathways. Molecular Carcinogenesis 2019;58:1450
Siyang Wen, Yilu Qin, Rui Wang, Liping Yang, Huan Zeng, Pengpeng Zhu, Qiao Li, Yuxiang Qiu, Shanchun Chen, Yongcan Liu, Yixuan Hou, Xi Tang, Manran Liu, Gang Tu. A novel Lnc408 maintains breast cancer stem cell stemness by recruiting SP3 to suppress CBY1 transcription and increasing nuclear β-catenin levels. Cell Death Dis 2021;12
Tingting Liu, Hongyue Wang, Zhiyong Liu, Jing Zhang, Yan Liu, Lin Zhang, Chunhui Zheng, Fei Liu, Chuanqiang Hou, Baojiang Li. Construction and Identification of New Molecular Markers of Triple-Negative Breast Cancer Stem Cells. Front. Oncol. 2021;11
M. Ergüven. Handbook of Cancer and Immunology. 2021.
Yizhe Zhang, Isao Naguro, Amy E. Herr. In Situ Single‐Cell Western Blot on Adherent Cell Culture. Angew Chem Int Ed 2019;58:13929
María Belén Novoa Díaz, Pedro Carriere, Claudia Gentili. How the interplay among the tumor microenvironment and the gut microbiota influences the stemness of colorectal cancer cells. World J Stem Cells 2023;15:281
Shuichi Fujiwara, Teruya Kawamoto, Yohei Kawakami, Yasufumi Koterazawa, Hitomi Hara, Toshiyuki Takemori, Kazumichi Kitayama, Shunsuke Yahiro, Kenichiro Kakutani, Tomoyuki Matsumoto, Takehiko Matsushita, Takahiro Niikura, Michiyo Koyanagi-Aoi, Takashi Aoi, Ryosuke Kuroda, Toshihiro Akisue. Acquisition of cancer stem cell properties in osteosarcoma cells by defined factors. Stem Cell Res Ther 2020;11
Kevin Dzobo, Naseeha Hassen, Dimakatso Alice Senthebane, Nicholas Ekow Thomford, Arielle Rowe, Hendrina Shipanga, Ambroise Wonkam, M. Iqbal Parker, Shaheen Mowla, Collet Dandara. Chemoresistance to Cancer Treatment: Benzo-α-Pyrene as Friend or Foe?. Molecules 2018;23:930
Taichi Nyui, Hironori Yoshino, Tetsuya Nunota, Yoshiaki Sato, Eichi Tsuruga. cGAS Regulates the Radioresistance of Human Head and Neck Squamous Cell Carcinoma Cells. Cells 2022;11:1434
Pey-Tsyr Chiou, Stephen Ohms, Philip G. Board, Jane E. Dahlstrom, Danny Rangasamy, Marco G. Casarotto. The Antiviral Drug Efavirenz in Breast Cancer Stem Cell Therapy. Cancers 2021;13:6232
Xinyi Li, Jiaqiang Huang, Yulin Kang, Xiyu Cheng, Qiong Yan, Lishu Zhang, Jingpu Fan, Hanli Xu. Cancer Stem Cell Biomarkers in the Nervous System. Front. Biosci. (Landmark Ed) 2023;28
Havva Marzban, Nastaran Pedram, Parnian Amini, Yasaman Gholampour, Navid Saranjam, Samira Moradi, Jeiran Rahvarian. Immunobiology of cancer stem cells and their immunoevasion mechanisms. Mol Biol Rep 2023;50:9559
Marina Montagnani Marelli, Monica Marzagalli, Fabrizio Fontana, Michela Raimondi, Roberta Manuela Moretti, Patrizia Limonta. Anticancer properties of tocotrienols: A review of cellular mechanisms and molecular targets. Journal Cellular Physiology 2019;234:1147
Jigna Joshi, Hitarth Patel, Hunayna Bhavnagari, Bhoomi Tarapara, Apexa Pandit, Franky Shah.
Eliminating Cancer Stem-Like Cells in Oral Cancer by Targeting Elementary Signaling Pathways
. Crit Rev Oncog 2022;27:65
Weiyan Zou, Jie Zhao, Yi Li, Zishu Wang, Haiqin Yan, Yudong Liu, Meiqun Sun, Jialu Zhuang, Junbin Wang.
Rat Bone Marrow-Derived Mesenchymal Stem Cells Promote the Migration and Invasion of Colorectal Cancer Stem Cells
. OTT 2020;Volume 13:6617
Sana Hachem, Hiam Fakhereddine, Amani Yehya, Wassim Abou-Kheir. Therapy Resistance in Prostate Cancer. 2020.
Marta Prieto-Vila, Ryou-u Takahashi, Wataru Usuba, Isaku Kohama, Takahiro Ochiya. Drug Resistance Driven by Cancer Stem Cells and Their Niche. IJMS 2017;18:2574
Xinyu Lin, Ying Wang, Kai Fang, Zijian Guo, Nan Lin, Lihua Li. The application of nanoparticles in theranostic systems targeting breast cancer stem cells: current progress and future challenges. Stem Cell Res Ther 2023;14
Ilaria Chiodi, Chiara Mondello. Life style factors, tumor cell plasticity and cancer stem cells. Mutation Research/Reviews in Mutation Research 2020;784:108308
Ying Su, Ru Chen, Zhongcheng Han, Rong Xu, Lili Ma, Reyina Wufuli, Hongbo Liu, Fang Wang, Lei Ma, Rui Chen, Jiang Liu. Clinical and Prognostic Significance of CD117 in Non-Small Cell Lung Cancer: A Systemic Meta-Analysis. Pathobiology 2021;88:267
Ghazaleh Baniebrahimi, Fatemeh Mir, Razieh Khanmohammadi. Cancer stem cells and oral cancer: insights into molecular mechanisms and therapeutic approaches. Cancer Cell Int 2020;20
Zhen Zeng, Minyang Fu, Yuan Hu, Yuquan Wei, Xiawei Wei, Min Luo. Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer. Mol Cancer 2023;22
Chiara Reina, Berina Šabanović, Chiara Lazzari, Vanesa Gregorc, Christopher Heeschen. Unlocking the future of cancer diagnosis – promises and challenges of ctDNA-based liquid biopsies in non-small cell lung cancer. Translational Research 2024;272:41
Mehmet Gunduz, Esra Gunduz, Shunji Tamagawa, Keisuke Enomoto, Muneki Hotomi. Cancer Stem Cells in Oropharyngeal Cancer. Cancers 2021;13:3878
Celso Alves, Eurico Serrano, Joana Silva, Carlos Rodrigues, Susete Pinteus, Helena Gaspar, Luis M. Botana, Maria C. Alpoim, Rui Pedrosa. Sphaerococcus coronopifolius bromoterpenes as potential cancer stem cell-targeting agents. Biomedicine & Pharmacotherapy 2020;128:110275
Rong Yu, Yinhui Hang, Hsiang-i Tsai, Dongqing Wang, Haitao Zhu. Iron metabolism: backfire of cancer cell stemness and therapeutic modalities. Cancer Cell Int 2024;24
Li-ping Gao, Ting-dong Li, Su-zhen Yang, Hui-min Ma, Xiang Wang, De-kui Zhang. NAT10-mediated ac4C modification promotes stemness and chemoresistance of colon cancer by stabilizing NANOGP8. Heliyon 2024;10:e30330
Fatma FIRAT, Canan TÜRKOĞLU, Feyzan OZDAL KURT, Hafize Seda VATANSEVER. Is Acteoside Effects on Colon Cancer Stem Cells Via Inflamation or Apoptosis?. 2022;32:372
Mei-Mei Li, Jun Yuan, Xin-Yuan Guan, Ning-Fang Ma, Ming Liu. Molecular subclassification of gastrointestinal cancers based on cancer stem cell traits. Exp Hematol Oncol 2021;10
Han‐Yun Hsieh, Weizhen Jia, Ze‐cheng Jin, Hiroyasu Kidoya, Nobuyuki Takakura. High expression of PSF1 promotes drug resistance and cell cycle transit in leukemia cells. Cancer Science 2020;111:2400
Hani Lee, Sojung Ha, SeokGyeong Choi, Soomin Do, Sukjoon Yoon, Yong Kee Kim, Woo-Young Kim. Oncogenic Impact of TONSL, a Homologous Recombination Repair Protein at the Replication Fork, in Cancer Stem Cells. IJMS 2023;24:9530
Sunyoung Seo, Nayoung Hong, Junhyuk Song, Dohyeon Kim, Yoonjung Choi, Daeyoup Lee, Sangyong Jon, Hyunggee Kim. Polymer Thin Film Promotes Tumor Spheroid Formation via JAK2-STAT3 Signaling Primed by Fibronectin-Integrin α5 and Sustained by LMO2-LDB1 Complex. Biomedicines 2022;10:2684
Yang Liu, Xiangdong Xu, Yuxuan Zhang, Yunzhao Mo, Xinlin Sun, Lingling Shu, Yiquan Ke. Paradoxical role of β8 integrin on angiogenesis and vasculogenic mimicry in glioblastoma. Cell Death Dis 2022;13
Mohd Anees, Neha Mehrotra, Sachchidanand Tiwari, Dinesh Kumar, Surender Kharbanda, Harpal Singh. Polylactic acid based biodegradable hybrid block copolymeric nanoparticle mediated co-delivery of salinomycin and doxorubicin for cancer therapy. International Journal of Pharmaceutics 2023;635:122779
Md. Ataur Rahman, Subbroto Kumar Saha, Md Saidur Rahman, Md Jamal Uddin, Md. Sahab Uddin, Myung-Geol Pang, Hyewhon Rhim, Ssang-Goo Cho. Molecular Insights Into Therapeutic Potential of Autophagy Modulation by Natural Products for Cancer Stem Cells. Front. Cell Dev. Biol. 2020;8
Soujanya J. Vastrad, Giri Ritesh, Sowmya S. V, Ganesan Rajalekshmi Saraswathy, Dominic Augustine, Khalid J. Alzahrani, Fuad M. Alzahrani, Ibrahim F. Halawani, Heba Ashi, Mohammed Alshahrani, Reem Nabil Hassan, Hosam Ali Baeshen, Kamatchi Sundara Saravanan, Kshreeraja S. Satish, Pravallika Vutukuru, Shankargouda Patil. Panoramic view of key cross-talks underpinning the oral squamous cell carcinoma stemness - unearthing the future opportunities. Front. Oncol. 2023;13
Changcan Li, Bao Jin, Hang Sun, Yunchao Wang, Haitao Zhao, Xinting Sang, Huayu Yang, Yilei Mao. Exploring the function of stromal cells in cholangiocarcinoma by three-dimensional bioprinting immune microenvironment model. Front. Immunol. 2022;13
Jilan Liu, Xianyun Qin, Dongfeng Pan, Bin Zhang, Feng Jin. Amino Acid-Mediated Metabolism: A New Power to Influence Properties of Stem Cells. Stem Cells International 2019;2019:1
Dawei Sun, Juan Liu, Yunfang Wang, Jiahong Dong. Co-administration of MDR1 and BCRP or EGFR/PI3K inhibitors overcomes lenvatinib resistance in hepatocellular carcinoma. Front. Oncol. 2022;12
Pavani Koka, Reddy Sailaja Mundre, Rohini Rangarajan, Yamini Chandramohan, Raghunandha Kumar Subramanian, Anuradha Dhanasekaran. Uncoupling Warburg effect and stemness in CD133+ve cancer stem cells from Saos-2 (osteosarcoma) cell line under hypoxia. Mol Biol Rep 2018;45:1653
Isabele Cristiana Iser, Paola de Andrade Mello, Samuel Davies, Jacqueline Fraga de Souza Santos, Diogo André Pilger, Andreia Buffon, Ana Paula Santin Bertoni, Marcia Rosângela Wink. A three‐dimensional microenvironment alters CD73 expression in cervical cancer. Cell Biochemistry & Function 2021;39:780
Taiga Seki, Yui Shimizu, Kyota Ishii, Yuzuki Takahama, Kazunori Kato, Tomohiro Yano. NK Cells Can Preferentially Target Prostate Cancer Stem-like Cells via the TRAIL/DR5 Signaling Pathway. Biomolecules 2021;11:1702
Changxian Shen, Duan-Liang Shyu, Min Xu, Linlin Yang, Amy Webb, Wenrui Duan, Terence M. Williams. Deregulation of AKT–mTOR Signaling Contributes to Chemoradiation Resistance in Lung Squamous Cell Carcinoma. 2022;20:425
YuanLin Sun, XueYuan Cao, YuChen Guo, Bin Liu, Yang Zhang, Ming Yi. The Prognostic and Molecular Landscape of Autophagy-Related Long Noncoding RNA in Colorectal Cancer. BioMed Research International 2022;2022:1
Alessandra Ardizzoia, Andrea Jemma, Serena Redaelli, Marco Silva, Angela Bentivegna, Marialuisa Lavitrano, Donatella Conconi. AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer. IJMS 2023;24:11455
Ta-Chin Lin, Kai-Hung Wang, Kuo-Hsiang Chuang, An-Pei Kao, Tsung-Cheng Kuo. Modulation of tumor stem cell characteristics by 17β-estradiol in human mesenchymal stem cells derived from ovarian endometrioma. Taiwanese Journal of Obstetrics and Gynecology 2019;58:338
Sara Tirendi, Barbara Marengo, Cinzia Domenicotti, Anna M. Bassi, Vanessa Almonti, Stefania Vernazza. Colorectal cancer and therapy response: a focus on the main mechanisms involved. Front. Oncol. 2023;13
Soumyadeep Mukherjee, Ashesh Baidya, Subhasis Barik. Cancer Diagnostics and Therapeutics. 2023.
Jiahui Lu. Cancer Stem Cells and Their Drug Resistance Mechanisms. HSET 2023;36:1334
Stefano Falone, Silvano Santini, Valeria Cordone, Giovanna Di Emidio, Carla Tatone, Marisa Cacchio, Fernanda Amicarelli. Extremely Low-Frequency Magnetic Fields and Redox-Responsive Pathways Linked to Cancer Drug Resistance: Insights from Co-Exposure-Based In Vitro Studies. Front. Public Health 2018;6
Ze Zhang, John K. Wiencke, Devin C. Koestler, Lucas A. Salas, Brock C. Christensen, Karl T. Kelsey. Absence of an embryonic stem cell DNA methylation signature in human cancer. BMC Cancer 2019;19
Soon Yong Park, Dong Gwang Lee, Ara Jo, Hyeongrok Choi, Joo Eon Lee, Ae Jin Jeong, Sun-Hee Leem, Woojin Jun, Sangin Shim, Sang-Kyu Ye, Jeong-Ki Min, Jin Woong Chung. Extracellular Microenvironmental Change by B16F10 Melanoma-derived Proteins Induces Cancer Stem-like Cell Properties from NIH3T3 Cells. Sci Rep 2019;9
Lin Ma, Lan Wang, Yating Shan, Muhammad Nafees, Elshoura Ihab, Ruhui Zhang, Fangjun Wang, Wu Yin, Gianpaolo Papaccio. Suppression of cancer stemness by upregulating Ligand-of-Numb protein X1 in colorectal carcinoma. PLoS ONE 2017;12:e0188665
Duoduo Lv, Liyu Chen, Lingyao Du, Lingyun Zhou, Hong Tang. Emerging Regulatory Mechanisms Involved in Liver Cancer Stem Cell Properties in Hepatocellular Carcinoma. Front. Cell Dev. Biol. 2021;9
Jinlai Wei, Xiangru Zheng, Wenjun Li, Xiaoli Li, Zhongxue Fu. Sestrin2 reduces cancer stemness via Wnt/β-catenin signaling in colorectal cancer. Cancer Cell Int 2022;22
Nan Wang, Ting Ma, Bin Yu. Targeting epigenetic regulators to overcome drug resistance in cancers. Sig Transduct Target Ther 2023;8
Stéphane Terry, Agnete S.T. Engelsen, Stéphanie Buart, Walid Shaaban Elsayed, Goutham Hassan Venkatesh, Salem Chouaib. Hypoxia-driven intratumor heterogeneity and immune evasion. Cancer Letters 2020;492:1
Yao Sun, Bo Li, Qian Cao, Tongjun Liu, Jiannan Li. Targeting cancer stem cells with polymer nanoparticles for gastrointestinal cancer treatment. Stem Cell Res Ther 2022;13
Clément Lecerf, Evodie Peperstraete, Xuefen Le Bourhis, Eric Adriaenssens. Propagation and Maintenance of Cancer Stem Cells: A Major Influence of the Long Non-Coding RNA H19. Cells 2020;9:2613
Petra Gener, Anna Ulldemolins, Simo Schwartz. Cancer, Complexity, Computation. 2020.
Kevin Dzobo, Dimakatso Alice Senthebane, Nicholas Ekow Thomford, Arielle Rowe, Collet Dandara, M. Iqbal Parker. Not Everyone Fits the Mold: Intratumor and Intertumor Heterogeneity and Innovative Cancer Drug Design and Development. OMICS: A Journal of Integrative Biology 2018;22:17